Pre-qualified active carriers, stabilizers, vitamins, and physiological co-factors utilized across integrated supplement and oral healthcare formulations.
As precision microbial therapies transition from specialized academic research into large-scale commercial pipelines, Lactobacillus salivarius (recently taxonomically classified under the broad genus Ligilactobacillus) has established itself as an indispensable commercial probiotic strain across pharmaceutical, nutraceutical, veterinary, and clinical nutrition sectors.
Lactobacillus salivarius produces potent low-molecular-weight bacteriocins, notably Salivaricin A2, Salivaricin B, and organic acid cascades that competitively exclude opportunistic periodontal and gastrointestinal pathobionts such as Streptococcus mutans, Helicobacter pylori, and Salmonella enterica.
By upregulating zonula occludens-1 (ZO-1), occludin, and claudin protein expression, pharmaceutical grades of L. salivarius significantly decrease paracellular flux across intestinal mucosal monolayers, rendering it essential for treating leaky gut syndromes and inflammatory bowel phenotypes.
Cell-wall surface-layer lipoteichoic acids trigger balanced Th1/Th2 cytokine shifts, dampening interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α) overexpression while orchestrating natural killer (NK) cell activation and secretor immunoglobulin A (sIgA) deployment.
Enterprise procurement officers and supply chain directors across North America, Europe, Japan, and the Middle East face distinct technological bottlenecks when sourcing bulk live microbial cultures. ShineHerb Biotech addresses these critical qualification criteria.
Conventional spray-drying causes massive thermal inactivation of vegetative bacterial membranes. ShineHerb utilizes cryogenic sub-zero snap-freezing paired with multi-stage programmable vacuum sublimation lyophilization, incorporating dual-action disaccharide cryoprotectants (trehalose and maltodextrin complex) to retain cell wall fluidity and enzymatic integrity across transoceanic shipping.
Continuous subculturing results in progressive genomic mutations, diminishing metabolic activity and bacteriocin expression. Our bioprocessing facility enforces a Master Cell Bank (MCB) and Working Cell Bank (WCB) regime authenticated via Whole Genome Sequencing (WGS), 16S rRNA gene sequencing, and Average Nucleotide Identity (ANI) benchmarking to eliminate phenotypic drift.
Standard dairy-based de Man, Rogosa, and Sharpe (MRS) growth broths contaminate final powders with residual casein, lactose, and bovine constituents. We offer custom non-GMO vegetable peptone, yeast hydrolysate, and plant-derived carbohydrate fermentation media specifically tailored for hypoallergenic, 100% vegan, Halal, and Kosher regulatory certification protocols.
| Analytical Parameter | Commercial Commodity Grade | ShineHerb Biotech Industrial Grade | Compendial Method / Monograph |
|---|---|---|---|
| Viable Plate Count (CFU/g) | 1.0 × 10¹⁰ to 5.0 × 10¹⁰ CFU/g | 1.0 × 10¹¹ to 5.0 × 10¹¹ CFU/g (Customizable) | ISO 19344 / IDF 232 (Flow Cytometry & Pour Plate) |
| Water Activity (a_w) | ≤ 0.25 | ≤ 0.12 (Controlled Desiccation) | USP <922> Chilled Mirror Dewpoint |
| Loss on Drying | ≤ 5.0% | ≤ 3.0% | EP 2.2.32 Vacuum Desiccation |
| Heavy Metals (As, Pb, Cd, Hg) | < 10.0 ppm cumulative | Pb <0.5 ppm, As <0.5 ppm, Cd <0.2 ppm, Hg <0.1 ppm | ICP-MS Standard Method |
| Non-Lactic Contaminants | < 1,000 CFU/g | < 100 CFU/g; Yeasts & Molds < 20 CFU/g | USP <2021> / EP Microbiological Examination |
| Enteropathogens (Salmonella, E. coli) | Negative / 10g | Negative in 25g (Zero Tolerance) | Real-time PCR / Rapid Culture Monograph |
Lactobacillus salivarius features remarkable phenotypic adaptability. We support multinational brand formulators across four primary industrial sectors.
Biofilm-targeting chewing gums, dissolvable lozenges, and dry toothpaste powders. Strains colonize the buccal epithelium, metabolize glucans, and inhibit volatile sulfur compound (VSC) generation caused by Porphyromonas gingivalis.
Targeted capsules for vaginal microflora restoration and infectious lactational mastitis therapy. High production of hydrogen peroxide (H₂O₂) and lactic acid inhibits Staphylococcus aureus colonization in human mammary ducts.
Feed-grade dry extrusion blends and functional dog chews. Clinical trials validate reductions in canine periodontal pathobionts and restoration of enteric microbial biodiversity following therapeutic antibiotic administration.
Heat-killed (tyndallized) cellular fractions containing peptidoglycan arrays, teichoic acids, and stable metabolites for water-based beverages, cosmetics, and functional gummies where live cell viability is technically unviable.
Achieving stable, hyper-concentrated live bacterial concentrates requires systematic control over metabolic flux, osmotic potential, and thermodynamic phase transitions.
Fermentation occurs inside 316L electropolished stainless-steel bioreactors under precise anaerobic headspaces (N₂/CO₂ sparging). We employ high-density fed-batch fermentation regimes with automated ammonium hydroxide / sodium hydroxide neutralization cascades. Controlling pH prevents the self-limiting accumulation of un-ionized lactic acid, boosting biomass generation by 300% compared to standard batch systems.
Harvesting occurs at the late-exponential growth curve where bacterial surface adhesins and membrane intactness peak. Cells undergo low-shear continuous disk-stack centrifugation followed by cross-flow ultrafiltration concentration. Hydrodynamic shear forces are strictly limited to prevent flagellar or cell-wall micro-fractures prior to formulating with cryoprotectant suspensions.
Concentrated cell pastes are blended with pharmaceutical-grade cryoprotectant complexes composed of non-reducing disaccharides, hydrolyzed vegetable proteins, and sodium ascorbate as an internal oxygen scavenger. Droplets are pelleted into liquid nitrogen (-196°C) to yield uniform cryo-pearls, eliminating slow crystal growth and preserving vital intracellular architecture throughout the sublimation phase.
For advanced gastric-resistant applications, lyophilized particles undergo fluid-bed top-spray microencapsulation with lipid, cellulose-acetate phthalate, or sodium alginate polymers. This creates an impermeable hydrophobic barrier that shields live bacteria from stomach pepsin and gastric acid (pH 1.5–2.5), releasing up to 98.5% of viable colony-forming units directly inside the target alkaline duodenum (pH 6.8–7.4).
Final grinding occurs inside class 100,000 cleanrooms maintained at relative humidity (RH) ≤20% and 18°C. Powders are conditioned through 60–100 mesh screens and vacuum-sealed into multi-layer composite aluminum foil drums with pharmaceutical-grade molecular-sieve desiccant pouches. Vacuum nitrogen-flushing guarantees residual oxygen levels <0.5%, halting oxidative degradation during international export transit.
Strategically based in the National Hi-Tech Industrial Development Zone of Xi'an, Shaanxi ShineHerb Biotech Co., Ltd. combines China's massive bio-fermentation scale with uncompromising global regulatory conformance.
Leveraging optimized domestic upstream substrate supply chains and large-scale bioreactor installations, our facility guarantees reliable commercial supplies exceeding 50 metric tons of probiotic freeze-dried powders annually, mitigating shortages for enterprise buyers.
Every outgoing shipment is released against explicit specifications aligned with USP, European Pharmacopoeia (EP), Food Chemicals Codex (FCC), and Chinese Pharmacopoeia (CP) requirements. Full batch documentation includes validated HPLC assays, plate counts, and ICP-MS metals testing.
Probiotics demand uninterrupted cold chains. We engineer export packaging with high-insulation expanded polypropylene (EPP) thermal shipping containers, dry ice replenishment architectures, and real-time USB/wireless temperature data loggers tracking every nautical or air-cargo mile.
Explore our extended catalog of pharmaceutical-grade amino acids, botanical extracts, marine oils, and peptide complexes engineered for co-formulation.
Direct technical guidance on microbial assays, packaging configurations, international cold-chains, and formulation compatibility.
We employ standardized serial dilution protocols utilizing reinforced MRS agar under strictly verified anaerobic incubator conditions (37°C for 48–72 hours) compliant with ISO 19344 and IDF 232 monographs. In addition, we correlate colony-forming unit (CFU) data with dual-stain fluorescence flow cytometry (SYTO 24 / Propidium Iodide) to differentiate actively metabolizing, dormant, and membrane-compromised bacterial cells per batch.
Stored unopened in original moisture-impermeable aluminum composite vacuum packaging at -18°C to -20°C, our powders retain ≥90% viability over 24 months. When stored under controlled ambient conditions (20°C to 25°C, RH <45%), historical real-time stability testing demonstrates an overage requirement of approximately 15% to 20% to maintain guaranteed label claims across an 18-month retail product cycle.
Yes. Our pharmaceutical blending suites allow homogeneous custom formulations blending Lactobacillus salivarius with complementary probiotics such as Bifidobacterium animalis, L. acidophilus, L. reuteri, or prebiotic soluble fibers (FOS, Inulin, Resistant Dextrin). All premix blending is conducted under cleanroom RH <20% to prevent water activity spikes that degrade sensitive freeze-dried cells.
Every batch ships with a lot-specific Certificate of Analysis (COA) containing microbiological, heavy metal, and assay data. ShineHerb Biotech maintains certified compliance with ISO 9001, ISO 22000, cGMP, HACCP, Halal, Kosher, and U.S. FDA facility registration. Full documentation sets including TSE/BSE declarations, non-GMO statements, and allergen-free certifications are supplied during qualification.
Standard enterprise production drums are 20 kg or 25 kg fiber drums lined with dual heat-sealed aluminum foil barrier bags. For R&D trials, pilot batches, or specialized high-potency applications (e.g., 500 Billion CFU/g grades), we accommodate sample trial MOQs starting at 1 kg, packaged inside puncture-resistant multi-layer barrier foil bags with integrated silica desiccant canisters.
Export shipments utilize temperature-validated insulated VIP/EPP shipping shippers fitted with dry ice blocks or calibrated -20°C phase-change material (PCM) gel packs engineered to maintain stable freezing conditions for up to 96 hours. For bulk commercial freight, temperature-monitored refrigerated air cargo (active reefer containers) routes are scheduled directly from Xi'an (XIY) and Shanghai (PVG) international air hubs.
Connect directly with ShineHerb's microbial application engineers in Xi'an. Receive detailed strain genetic sequencing reports, customized carrier options, stability testing documentation, and rapid cold-chain sample delivery for your lab qualification.